Skip to main content
Home
Division of Cancer Prevention
Making cancer prevention possible
  • Home
  • Major Programs
    • Major Programs
    • Alliance of Glycobiologists for Cancer Research
    • Barrett's Esophagus Translational Research Network (BETRNet)
    • Cancer Immunoprevention Network (CIP-Net)
    • Cancer Prevention Clinical Trials Network (CP-CTNet)
    • Cancer Prevention Fellowship Program (CPFP)
    • Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT)
    • Cancer Screening Research Network (CSRN)
    • Cancer Treatment Tolerability Consortium
    • Consortium for Imaging and Biomarkers (CIB)
    • Discovery and Development of Natural Products for Cancer Interception and Prevention (DDNP-CIP)
    • Early Detection Research Network (EDRN)
    • HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network
    • Liquid Biopsy Consortium
    • Lung Cancer Screening Image Library
    • Multi-Cancer Detection (MCD) Research
    • NCI Cervical Cancer ‘Last Mile’ Initiative
    • NCI Community Oncology Research Program (NCORP)
    • Pancreatic Cancer Detection Consortium (PCDC)
    • Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)
    • Pre-Cancer Atlas (PCA)
    • PREVENT Cancer Preclinical Drug Development Program (PREVENT)
    • Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    • Small Cell Lung Cancer (SCLC) Consortium
    • Supportive Care and Symptom Management
    • Translational and Basic Science Research in Early Lesions (TBEL) Program
    • Translational Liver Cancer (TLC) Consortium
    • US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)
  • Research Groups
    • Research Groups
    • Biometry
    • Breast and Gynecologic Cancer
    • Cancer Biomarkers
    • Chemopreventive Agent Development
    • Community Oncology and Prevention Trials
    • Early Detection
    • Gastrointestinal and Other Cancers
    • Lung and Upper Aerodigestive Cancer
    • Nutritional Science
    • Prostate and Urologic Cancer
  • Clinical Trials
    • Clinical Trials
    • Clinical Trials Search
    • Landmark Trials
    • Clinical Trials Management
  • Funding & Grants
    • Funding & Grants
    • Funding Opportunities
    • Funded Grants
    • Grantsmanship Resources
    • Workforce Initiatives
  • Resources
    • Resources
    • Publication Search
    • Biorepositories
    • Cancer Data Access System (CDAS)
  • News & Events
    • News & Events
    • News
    • Blog
    • DCP Updates
    • Meetings and Events
    • Videos and Webinars
    • Infographics
  • About DCP
    • About DCP
    • Scientific Scope
    • Director
    • DCP Leadership
    • History and Timeline
    • Staff Directory
  1. Home
  2. Major Programs
  3. Cancer Screening Research Network (CSRN)

CSRN Frequently Asked Questions (FAQs)

Vanguard Study FAQs

  • Study Participants
  • Study Design
  • Standard of Care Screenings
  • Multi-Cancer Detection (MCD) Assays
  • Other
    • Cancer Screening Research Network (CSRN)
      • Use of NCI Clinical Trials Infrastructure
      • Relevant Links
      • CSRN Frequently Asked Questions (FAQs)
        • Vanguard Study FAQs
      • Achived Information About the CSRN

FOLLOW US AT:

@NCIPrevention

@NCISymptomMgmt

@NCICastle

The National Cancer Institute

NCI Division of Cancer Prevention

POLICIES

DCP Home

Contact DCP

Policies

Disclaimer Policy

Accessibility

FOIA

HHS Vulnerability Disclosure

NCI'S PDQ® EVIDENCE-BASED SUMMARIES

Cancer Prevention

Screening/Detection/Testing for Cancer

Supportive and Palliative Care

GENERAL INFORMATION

Cancer Prevention, Specific Cancers, Clinical Trials

Cancer Screening Topics For People Who Have No Symptoms

Managing The Side Effects of Cancer and Its Treatment

Coping With Cancer

US Preventive Services Task Force Recommendations About Cancer

NIH COVID-19 Resources

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®